Page 148 - JSOM Winter 2018

Author Contributions 23. Rovati LC, Girolami F, Persiani S. Crystalline glucosamine sul-
All authors approved the final version of the manuscript. fate in the management of knee osteoarthritis: efficacy, safety and
pharmacokinetic properties. Ther Adv Musculoskelet Dis. 2012;
4(3):167–180.
References 24. Hamerman D. The biology of osteoarthritis. N Engl J Med. 1998;
1. Knapik JJ, Pope R, Orr R, et al. Osteoarthritis: pathophysiology, 320(20):1322–1330.
risk factors and exercise for reducing pain and disability. J Spec 25. Altman RD. Glucosamine therapy for knee osteoarthritis: phar-
Oper Med. 2018; 18(3):94–102. macokinetic considerations. Expert Rev Clin Pharmacol. 2009;2
2. Kraus VB, Blanco FL, Englund M, et al. Call for standarized defi- (4):359–371.
nitions of osteoarthritis and risk stratification for clinical trials 26. Marra J. The state of dietary supplements. Even a slight increase
and clinical use. Osteoarthritis Cartilage. 2015;23:1233–1241. in growth are better than no growth at all. Nutraceutical World.
3. Williams VF, Clark LL, Oh GT. Update: osteoarthritis and spon- 2002;Nov/Dec:32–40.
dylosis, active component, US Armed Forces, 2010-2015. MSMR. 27. Byrne J. Glucosamine market reaching maturity. https://www
2016;23(9):14–22. .nutraingredients.com/Article/2010/04/15/Glucosamine-market
4. Armed Forces Health Surveillance Center. Osteoarthritis and -reaching-maturity. Accessed 11 June 2018.
spondylosis, active component, US Armed Forces, 2000–2009. 28. Olivo L. Critical connections for joint health. Consumers turn
MSMR. 2010;17(12):6–11. to dietary supplements for protection at all walks of life. http://
5. Patzkowski JC, Rivera JC, Ficke JR, et al. The changing face of www.nutraceuticalsworld.com/issues/2015-04/view_features
disability in the US Army: the Operation Enduring Freedom and /critical-connections-for-joint-health. Accessed 11 June 2018.
Operation Iraqi Freedom effect. J Am Acad Orthop Surg. 2012; 29. Morrow JD. Why the United States still needs improved dietary
20(Suppl 1):S23–S30. supplement regulation and oversight. Clin Pharmacol Ther. 2008;
6. Spector TD, MacGregor AJ. Risk factors for osteoarthritis: genet- 83(3):391–393.
ics. Osteoarthritis Cartilage. 2004;12(Suppl):S39–S44. 30. Knapik JJ, Trone DW, Austin KG, et al. Prevalence, adverse ef-
7. Silverwood V, Blagojevic-Bucknall M, et al. Current evidence on risk fects, and factors associated with dietary supplement and nutri-
factors for knee osteoarthritis in older adults: a systematic review tional supplement use by United States Navy and Marine Corps
and meta-analysis. Osteoarthritis Cartilage. 2015;23:507–515. personnel. J Acad Nutr Diet. 2016;116(9):1423–1442.
8. Thompson RC, Oegema TR, Lewis JL, et al. Osteoarthritic 31. Austin KG, Farina EK, Lieberman HR. Self-reported side- effects
changes after acute transarticular load: an animal model. J Bone associated with the use of dietary supplements in an Armed
Jt Surg. 1991;73A:990–1001. Forces population. Drug Test Anal. 2016;8(3-4):287–295.
9. Qi C, Changlin H. Effects of moving training on histology and bio- 32. Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in
markers levels of articular cartilage. J Surg Res. 2006;135:352–363. humans: a review of effects on glucose metabolism, side effects,
10. Newton PM, Mow VC, Gardner TG, et al. The effect of lifelong safety considerations and efficacy. Food Chem Toxicol. 2004;43:
exercise on canine articular cartilage. Am J Sports Med. 1997;25 187–201.
(3):282–287. 33. Rubin BR, Talent JM, Kongtawelert P, et al. Oral polymeric
11. Alentorn-Geli E, Samuelsson K, Musahl V, et al. The association N-acetyl-d-glucosamine and osteoarthritis. J Am Osteopath As-
of recreational and competitive running with hip and knee osteo- soc. 2001;101(6):339–244.
arthritis: a systematic review and meta-analysis. J Orthop Sports 34. Wu D, Huang Y, Gu Y, Fan W. Efficacies of different prepara-
Phy Ther. 2017;47(6):373–390. tions of glucosamine for treatment of osteoarthritis: a meta-anal-
12. Fransen M, McConnell S. Land-based exercise for osteoarthri- ysis of randomized controlled trials. Int J Clin Pract. 2013;67(6):
tis of the knee: a metaanalysis of randomized controlled trials. J 585–594.
Rheumatol. 2009;36:1109–1117. 35. Vlad SC, LaValley MP, McAlindon TE, et al. Glucosamine
13. Latham N, Liu CJ. Strength training in older adults: the benefits for pain in osteoarthritis. Why do trial results differ? Arthritis
for osteoarthritis. Clin Geriatr Med. 2010;26:445–459. Rheum. 2007;56(7):2267–2277.
14. Fransen M, McConnell S, Hernandez-Molina G, et al. Does land- 36. Eriksen P, Bartels EM, Altman RD, et al. Risk of bias and brand
based exercise reduce pain and disability associated with hip explain the observed inconsistency in trials on glucosamine for
osteoarthritis? A meta-analysis of randomized controlled trials. symptomatic relief of osteoarthritis: a meta-analysis of placebo-
Osteoarthritis Cartilage. 2010;18:613–620. controlled trials. Arthritis Care Res. 2014;66(12):1844–1855.
15. Kang JW, Lee MS, Posadzki P, et al. Tai chi for the treatment of 37. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin
osteoarthritis: a sysyematic review and meta-analysis. BMJ Open. sulfate, and the two in combination for painful knee osteoarthri-
2011;1:e000035. tis. N Engl J Med. 2006;354(8):795–808.
16. Uthman OA, vanderWindt DA, Jordan JL, et al. Exercise for 38. Uitterlinden EJ, Jahr H, Koevort JLM, et al. Glucosamine de-
lower limb ostroarthritis: systematic review incorporating trial se- creases expression of anabolic and catabolic genes in human os-
quential analysis and network meta-analysis. Br Med J. 2013;347. troarthritic cartilage explants. Osteoarthritis Cartilage. 2006;14:
17. Juhl C, Christensen R, Roos EM, et al. Impact of exercise type 250–257.
and dose on pain and disability in knee osteoarthritis. Arthritis 39. Hoffer LJ, Kaplan LN, Hamadeh MJ, et al. Sulfate could me-
Rheum. 2014;66(3):622–636. diate the therapeutic effect of glucosamine sulfate. Metabolism.
18. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoar- 2001;50(7):767–770.
thritis of the knee: a Cochrane systemic review. Br J Sports Nutr. 40. Kongtharvonskul J, Anothaisintawee T, McEvoy M, et al. Effi-
2015;49:1554–1557. cacy and safety of glucosamine, diacerein, and NSAIDs in osteo-
19. Beumer L, Wong J, Warden SJ, et al. Effects of exercise and man- arthritis knee: a systematic review and network meta-analysis.
ual therapy on pain associated with hip osteoarthritis: a systematic Eur J Med Res. 2015;20:4.
review and meta-analysis. Br J Sports Nutr. 2016;50:458–463. 41. Liu X, Machado GC, Eyles JP, et al. Dietary supplements for
20. Bartholdy C, Juhl C, Christensen R, et al. The role of muscle treating osteoarthritis: a systematic review and meta-analysis. Br
strengthening in exercise therapy for knee osteoarthritis: a sys- J Sports Med. 2018;52:167–175.
tematic review and meta-regression of randomized trials. Semin 42. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, con-
Arthritis Rheum. 2017;47:9–21. droitn or placebo in patients with osteoarthritis of hip or knee:
21. Magni NE, McNair PJ, Rice DA. The ffects of resistance training network meta-analysis. Br Med J. 2010;341:C4675.
on muscle strength, joint pain, and hand function in individuals 43. Gallagher B, Tjoumakaris FP, Harwood MI, et al. Chondro-
with hand osteoarthritis: a systematic review and meta-analysis. protection and prevention of osteoarthritis progression of the
Arthritis Res Ther. 2017;19:131. knee. A systematic review of treatment agents. Am J Sports Med.
22. Pisters MF, Veenhof C, vanMeeteren NLU, et al. Long-term 2014;43(3):734–744.
effectiveness of exercise therapy in patients with osteoarthri- 44. Towheed TE, Maxwell L, Anastassiades TP, et al. Glucosamine
tis of the hip or knee: a systematic review. Arthritis Rheum. therapy for treating osteoarthritis. Cochrane Database Syst Rev.
2007;57(7):1245–1253. 2009;18(2):CD002946.

146 | JSOM Volume 18, Edition 4 / Winter 2018